Nektar Therapeutics reported $-113596000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Agios Pharmaceuticals AGIO:US $ -89.16M 0.07M
ALKERMES ALKS:US -19659000 24.08M
Amgen AMGN:US $ 2378M 1550M
Astrazeneca AZN:US -1674000000 2.8B
Baxter International BAX:US $ 495M 71M
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Biogen BIIB:US $ 794M 308.3M
Bluebird Bio BLUE:US $ -216.95M 23.88M
Bristol Myers Squibb BMY:US $ 1996M 281M
Cara Therapeutics CARA:US $ -1124000 29.75M
Dr.Reddys Laboratories DRRD:IN 10.66B 6.15B
Eisai 4523:JP Y 5499M 49908M
Eli Lilly And LLY:US $ 1476M 72.6M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
Exelixis EXEL:US $ 51.62M 71.39M
Gilead Sciences GILD:US $ 3842M 1596M
GlaxoSmithKline GSK:LN 1.94B 263M
Halozyme Therapeutics HALO:US $ 75.59M 17.46M
Immunogen IMGN:US $ -34.23M 6.86M
IONIS PHARMACEUT IONS:US $ -86M 4.4M
Ironwood Pharmaceuticals IRWD:US $ 65.17M 0.07M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 4826M 3212M
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Novartis NOVN:VX 3.23B 246M
Pfizer PFE:US $ 7647M 1733M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Seattle Genetics SGEN:US $ -297.96M 208.36M
Takeda 4502:JP Y 97427M 151125M
Teva Pharmaceutical TEVA:IT 623M 41M
Xencor XNCR:US $ -41.9M 50.99M
YTE INCY:US $ 235.41M 94.57M